반응식
[C:1]([C:3]1[CH:8]=[CH:7][C:6]([CH:9]2[N:14]([CH2:15][C:16](O)=[O:17])[C:13](=[O:19])[N:12]([C:20]3[CH:25]=[CH:24][CH:23]=[C:22]([C:26]([F:29])([F:28])[F:27])[CH:21]=3)[C:11]([CH3:30])=[C:10]2[C:31]([CH:33]2[CH2:35][CH2:34]2)=[O:32])=[CH:5][CH:4]=1)#[N:2].C1(N=C=NC2CCCCC2)CCCCC1.[C:51]([C:53]1[CH:58]=[CH:57][C:56]([S:59]([NH2:62])(=[O:61])=[O:60])=[CH:55][CH:54]=1)#[N:52]>CN(C)C1C=CN=CC=1.ClCCl>[C:1]([C:3]1[CH:8]=[CH:7][C:6]([CH:9]2[N:14]([CH2:15][C:16]([NH:62][S:59]([C:56]3[CH:55]=[CH:54][C:53]([C:51]#[N:52])=[CH:58][CH:57]=3)(=[O:60])=[O:61])=[O:17])[C:13](=[O:19])[N:12]([C:20]3[CH:25]=[CH:24][CH:23]=[C:22]([C:26]([F:28])([F:27])[F:29])[CH:21]=3)[C:11]([CH3:30])=[C:10]2[C:31]([CH:33]2[CH2:35][CH2:34]2)=[O:32])=[CH:5][CH:4]=1)#[N:2]참가 물질
6
반응물 3
생성물 1
시약·촉매·용매 2
실험 절차
A mixture of [6-(4-cyanophenyl)-5-(cyclopropylcarbonyl)-4-methyl-2-oxo-3-[3-(trifluoromethyl)phenyl]-3,6-dihydropyrimidin-1(2H)-yl]acetic acid (Example 31) (100 mg, 0.21 mmol), 1,3-dicyclohexylcarbodiimide (41.5 mg, 0.23 mmol), 4-cyanobenzene-1-sulfonamide (41.5 mg, 0.23 mmol) and 4-dimethylaminopyridine (28 mg, 0.23 mmol) in dichloromethane (4 ml) is stirred for 48 hours. The product is extracted with dichloromethane, washed with 2 N hydrochloric acid and brine, dried over anhydrous magnesium sulfate, filtered and concentrated. The residue is purified by preparative HPLC (RP18 column; eluent: acetonitrile/water 10:90→90:10).
후처리
- extractionThe product is extracted with dichloromethane
- washwashed with 2 N hydrochloric acid and brine
- dry with materialdried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated
- customThe residue is purified by preparative HPLC (RP18 column; eluent: acetonitrile/water 10:90→90:10)
출처 및 근거
- ORD 기록
- ord-bd567958cfad427da91267de19faf5a2
- 출처 데이터셋
- uspto-grants-2012_01
- 특허 번호
- US08101615B2
연결된 노트
불러오는 중…